Notably, we found that high staining frequencies of glycan structures recognized by LSECtin were associated with a worse prognosis, and this association was particularly pronounced in the subgroup of ER+ breast cancers, specifically in tumors of the G2 gray zone (Fig. 4E and F), with G3 gray zone tumors showing a trend (Fig. 4H). This evidence concerns the gene ESR1 and breast cancer.